Keybanc Initiates Coverage On LifeMD with Overweight Rating, Announces Price Target of $12
Portfolio Pulse from Benzinga Newsdesk
Keybanc has initiated coverage on LifeMD (NASDAQ:LFMD) with an Overweight rating and a price target of $12.
June 05, 2024 | 9:36 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Keybanc has initiated coverage on LifeMD with an Overweight rating and a price target of $12, indicating a positive outlook for the stock.
The initiation of coverage with an Overweight rating and a price target of $12 by Keybanc suggests a positive sentiment towards LifeMD's stock. This is likely to attract investor interest and potentially drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100